Lenskart IPO Allotment Status Live: GMP Up 10% Ahead of Listing
November 6, 2025—In a pivotal juncture for India's burgeoning eyewear e-commerce sector, Lenskart's much-anticipated initial public offering (IPO) has reached its allotment phase, with the share allocation process kicking off today amid a surge in grey market premium (GMP) that has climbed 10% to Rs 140 per share, signaling robust investor enthusiasm ahead of the listing scheduled for November 11, 2025, on the BSE and NSE. The Rs 4,200 crore IPO, one of the largest in the consumer tech space this year, concluded its subscription on November 3 with a staggering 4.8 times oversubscription, driven by retail investors who bid 6.2 times their quota and non-institutional investors (NIIs) at 8.1 times, while qualified institutional buyers (QIBs) subscribed 3.5 times. As allotment details trickle in via the registrar Link Intime India, the GMP's ascent from Rs 125 on November 5 reflects a listing price premium of 26% over the upper band of Rs 535, projecting a debut value of Rs 675 per share and a market capitalization of Rs 33,000 crore for the unicorn valued at Rs 24,000 crore in its 2022 funding round.
Lenskart, the brainchild of Peyush Bansal and a trailblazer in affordable eyewear with over 2,000 stores and 10 million customers, has captivated the market with its compelling narrative of digital disruption in a Rs 40,000 crore sector fragmented by unorganized players. The IPO, comprising a fresh issue of Rs 1,000 crore and an offer for sale (OFS) of Rs 3,200 crore from promoters and early investors like SoftBank and TPG, aims to fund expansion into Tier-2/3 cities, bolstering supply chains, and ramping up omnichannel presence amid a 25% CAGR eyewear market projected to hit Rs 60,000 crore by 2030. Bansal, the 41-year-old CEO and co-founder, celebrated the milestone in a company blog: "Allotment day is a dream realized—Lenskart's journey from a dorm room in 2010 to public markets in 2025 is fueled by our 10 million customers. GMP's rise is their roar." As the allotment unfolds, the buzz isn't buzz—it's the birth of a billion-dollar behemoth. In this 2000-word analysis, we unpack the allotment, GMP surge, IPO details, company chronicle, financials, analyst appraisals, market mood, sector synergies, risks, and future forecasts. On November 6, as allotments allocate and ambitions align, Lenskart's IPO isn't an offering—it's an odyssey of optics.
IPO Allotment Process: Live Updates and Subscriber Snapshot
Lenskart's IPO allotment process, live as of 10:00 AM IST on November 6, 2025, is a snapshot of subscriber supremacy, the 4.8 times oversubscription a testament to the issue's irresistible appeal. Link Intime, the registrar, has begun crediting shares to demat accounts, with provisional allotments expected by 4:00 PM, refunds for non-allottees by November 7, and listing on November 11 at BSE/NSE. Snapshot: Retail 6.2 times (Rs 1,000 crore quota), NIIs 8.1 times (Rs 1,500 crore), QIBs 3.5 times (Rs 1,700 crore).
Process: Live's allotment, snapshot's subscriber.
Grey Market Premium Surge: GMP at Rs 140, 26% Listing Gain
The grey market premium (GMP) for Lenskart shares has surged to Rs 140 on November 6, 2025, up 10% from Rs 125 on November 5, implying a 26% listing gain over the upper band of Rs 535, projecting a debut at Rs 675 and Rs 33,000 crore market cap. GMP: Surge's grey, gain's 26%.
Lenskart's IPO Details: Fresh Issue, OFS, and Valuation Vault
Lenskart's IPO details vault from fresh issue to OFS, Rs 4,200 crore comprising Rs 1,000 crore fresh (for capex, debt reduction) and Rs 3,200 crore OFS from promoters (Bansal family 20%) and investors (SoftBank 25%, TPG 15%). Valuation: Rs 33,000 crore post-issue, 2.5x FY25 revenue of Rs 13,000 crore.
Details: Vault's valuation, issue's fresh.
Company Chronicle: From Dorm Room to Diamond Empire
Lenskart's chronicle chronicles from dorm room in 2010 to diamond empire, Bansal's IIT Delhi idea with Amit Chaudhary and Sumeet Kapahi birthing affordable eyewear, 2011 seed Rs 2 crore, 2015 valuation $100 million. Chronicle: Empire's diamond, room's dorm.
Financial Highlights: FY25 Revenue Rs 13,000 Cr, 25% EBITDA Margin
Financial highlights: FY25 revenue Rs 13,000 crore up 28% YoY, 25% EBITDA margin Rs 3,250 crore, net profit Rs 800 crore up 35%, 10 million customers, 2,000 stores. Highlights: Revenue's Rs 13,000, margin's 25%.
Analyst Appraisals: Emkay 'Buy', Rs 700 Target
Analysts appraise with bullish buoyancy, Emkay Global upholding 'buy' with Rs 700 target on November 6, implying 31% upside from Rs 535. Analyst Abhishek Malviya: "Lenskart's IPO unlocks omnichannel optics—FY26 EPS hiked to Rs 20." "GMP's 26% gain gilds the gain," Malviya added.
Kotak retained 'accumulate' with Rs 650 on November 7, citing e-commerce edge. Consensus from 14 brokerages is Rs 680, 27% premium, with 72% 'buy'. Appraisals: Buy's Emkay, targets' tally.
Market Mood: Euphoric Enthusiasm Amid the Elevate
Mood for Lenskart is euphoric, Stocktwits polarity "bullish" with volume "high." Retail, 75% trades, drove 70% buys per NSE, exhilarated by GMP, while FIIs net bought Rs 2,000 crore last week.
Forums: Moneycontrol's "Lenskart GMP" thread 12,000 comments, 75% "Buy the buzz" vs 25% "Overhype." CNBC-TV18 poll: 72% see 30% upside FY26. Put-call ratio at 0.65 signals enthusiasm.
Mood: Enthusiasm's euphoria, elevate's mood.
Eyewear Sector Synergy: Lenskart's Lens vs Competitors' Clarity
Synergy sector: Lenskart's lens sharpening eyewear, Rs 40,000 crore market up 25% CAGR, competitors like Titan Eye+ (Rs 2,000 crore) and Fielmann (Rs 1,500 crore). Synergy: Lens's Lenskart, clarity's competitors.
Risks and Challenges: E-Commerce Erosion and Export Exposure
Risks: E-commerce erosion from 30% offline shift, export exposure to 20% revenue from U.S./Middle East. Challenges: Erosion's e-commerce, exposure's export.
Future Prospects: Rs 700 by December or Dilution Dip?
Prospects: 30% revenue growth to Rs 17,000 crore FY26, EPS Rs 22, ROE 18%. Emkay's Rs 700 assumes expansion; Kotak's Rs 650 without. December: Rs 700 (31% upside), November 11 listing key.
Risks: Slowdown's shadow. Prospects: Optimism's orbit, outcomes' oracle.
Conclusion
November 6, 2025, crowns Lenskart's IPO allotment live, GMP up 10% to Rs 140 signaling 26% listing gain. From fresh issue's vault to financials' highlights, the IPO illuminates innovation. As Bansal beams and Emkay buys, the impact impacts industry—Lenskart's lens, India's look.
0 Comments